The DermaSensor device is a handheld, non-invasive device that uses light, through a technology called elastic scattering spectroscopy (ESS) and artificial intelligence to evaluate skin lesions in a matter of seconds. The internal processor analyzes the light reflected from a lesion to objectively help trained healthcare professionals evaluate whether a skin lesion is cancerous through its “Higher Risk / Lower Risk” output.

How the Technology Works

  1. The tip of the DermaSensor™ reflects and records quick bursts of light off the lesion’s cellular structures.  
  2. The light is analyzed by the built-in computer to distinguish different types of malignant skin lesions (including melanomas, squamous cell carcinomas, and basal cell carcinomas) from benign skin lesions.
  3. By examining the difference in light scattering, DermaSensor™ determines if the skin lesion is at “Higher Risk” or “Lower Risk,” of malignancy with an instantaneous and actionable output.